GENX Fundamental Analysis - GENIX PHARMACEUTICALS CORP

Fundamental Rating

We assign a fundamental rating of 0 out of 10 to GENX. GENX was compared to 4 industry peers in the Personal Care Products industry. GENX may be in some trouble as it scores bad on both profitability and health. GENX is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year GENX has reported negative net income.

In the past year GENX has reported a negative cash flow from operations.

In the past 5 years GENX always reported negative net income.

GENX had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -214.87%, GENX is not doing good in the industry: 75.00% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-214.87%
ROE	N/A
ROIC	N/A

ROA(3y)-717.5%

ROA(5y)-440.12%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of GENX (30.00%) is comparable to the rest of the industry.

GENX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	30%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

GENX does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for GENX remains at a similar level compared to 1 year ago.

Compared to 5 years ago, GENX has more shares outstanding

GENX has a worse debt/assets ratio than last year.

2.2 Solvency

GENX has an Altman-Z score of -313.32. This is a bad value and indicates that GENX is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of -313.32, GENX is not doing good in the industry: 75.00% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-313.32

ROIC/WACCN/A

WACC6.33%

2.3 Liquidity

A Current Ratio of 0.04 indicates that GENX may have some problems paying its short term obligations.

GENX has a Current ratio of 0.04. This is in the lower half of the industry: GENX underperforms 75.00% of its industry peers.

A Quick Ratio of 0.04 indicates that GENX may have some problems paying its short term obligations.

GENX has a Quick ratio of 0.04. This is in the lower half of the industry: GENX underperforms 75.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.04
Quick Ratio	0.04

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 97.20% over the past year.

GENX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -63.30%.

GENX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -50.46% yearly.

EPS 1Y (TTM)97.2%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-80%

Revenue 1Y (TTM)-63.3%

Revenue growth 3YN/A

Revenue growth 5Y-50.46%

Sales Q2Q%-100%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

GENX does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

GENIX PHARMACEUTICALS CORP

TSX-V:GENX (5/28/2025, 7:00:00 PM)

0.035

+0.01 (+16.67%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupHousehold & Personal Products

GICS IndustryPersonal Care Products

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners19.24%

Ins Owner ChangeN/A

Market Cap2.07M

Analysts0

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	518.18
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)0

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0

FCFYN/A

OCF(TTM)0

OCFYN/A

SpS0

BVpS-0.02

TBVpS-0.02

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-214.87%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	30%
FCFM	N/A

ROA(3y)-717.5%

ROA(5y)-440.12%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0.07

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.04
Quick Ratio	0.04
Altman-Z	-313.32

F-Score4

WACC6.33%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)97.2%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-80%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-63.3%

Revenue growth 3YN/A

Revenue growth 5Y-50.46%

Sales Q2Q%-100%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y64.86%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y14.77%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y13.6%

OCF growth 3YN/A

OCF growth 5YN/A

GENIX PHARMACEUTICALS CORP (GENX.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens